Acquisitions (Tables)

9 Months Ended

Oct. 31, 2013

Schedule of Allocation of the Acquisition Purchase Price

Based on the Company’s allocation of the purchase price, the acquisition had the following effect on the Company’s condensed consolidated financial position as of the closing date:

(in thousands)	Diberil
Working capital	$	3,592
Property and equipment		33,500
Goodwill		4,025
Other intangible assets		1,000
Other assets		9,131
Other noncurrent liabilities		(16,981	)
Total purchase price	$	34,267

Schedule of Unaudited Pro Forma Condensed Consolidated Revenues, Net Income (Loss) and Net Income (Loss) Per Share

Assuming the remaining 50% of Diberil had been acquired at February 1, 2012, the unaudited pro forma condensed consolidated revenues, net income (loss), and net income (loss) per share of the Company would be as follows:

	Three Months		Nine Months
	Ended October 31,		Ended October 31,
(in thousands, except per share data)	2012		2012
Revenues	$	281,281	$	871,222
Net income (loss) attributable to Layne Christensen Company		8,476		(8,303	)
Basic income (loss) per share attributable to Layne Christensen Company	$	0.43	$	(0.43	)
Diluted income (loss) per share attributable to Layne Christensen Company	$	0.43	$	(0.42	)